Background
Colleen Julian, PhD, received her BA in ecology and evolutionary biology and her MS in integrative physiology from the University of Colorado Boulder, and her PhD in health and behavioral sciences from the University of Colorado Denver Health Sciences Center.
Research + Funding
From 2013 to 2017, Dr. Julian was a Building Interdisciplinary Research Careers in Women's Health (BIRCWH) scholar where she pursued research for her project, “Hypoxia-Associated Impairment of Fetal Growth: Epigenomic Perspectives.” The BIRCWH scholarship and Ludeman Center provided the platform from which Dr. Julian launched her independent research career. As a principal investigator, she has since obtained multiple grants from the National Institutes of Health and the American Heart Association to support women's health research in her lab. She recognizes the continued role of the Ludeman Center whose work, she says, “focuses on growing a community of highly motivated scientists from multiple disciplines that is devoted to improving women’s health. Through extensive support, networking and professional development opportunities for early-career researchers and established investigators alike, the Ludeman Center truly represents a pillar of progress on our campus.”
Transforming Women’s Health
“I'm driven by and appreciative of the fact that my purpose for coming into the lab every day is to work towards improving health outcomes for women and children.”—Dr. Julian
Dr. Julian’s current research priority centers on the mechanisms driving human adaptation to hypoxia and the role of disrupted oxygen homeostasis in regulating fetal growth and maternal vascular adaptation to pregnancy. Using the natural laboratory of high altitude, their work takes advantage of naturally occurring variability between human populations in the frequency of hypoxia-associated vascular disorders of pregnancy to study genes and biologic pathways important for the development of preeclampsia and fetal growth restriction. The Julian Lab is working to identify potential therapeutic targets to improve maternal and infant health outcomes and to design more effective methods to detect individuals at risk for hypoxia-related disease.